In most cancers, these properties of Rac1 are attributed to gain-of-function mutations in the Rac1 gene; however, in PCa, Rac1, like most other Rho family members, is rarely mutated, hence tumorigenesis may be attributed to associated regulatory proteins. Here, RAC1 is linked to posterior cortical atrophy.